Literature DB >> 35597405

Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake.

Ilgin Kimiz-Gebologlu1, Suphi S Oncel2.   

Abstract

Exosomes are nanovesicles with different contents that play a role in various biological and pathological processes. It offers significant advantages over other delivery systems such as liposomes and polymeric nanoparticles. Although exosomes are expected to be effective therapeutic agents, their optimal use remains a challenge. The development of methods for large-scale production, isolation, and drug loading is necessary to improve their efficiency and therapeutic potential. In this review, after mentioning general properties and biological functions of the exosomes, details of their potential for use in the drug delivery system are presented. For this purpose, methodologies for the large-scale production of exosomes, exosome isolation, exosomal cargo loading, and exosome uptake by the recipient cell are reviewed. The current challenges and potential directions of this new area of drug delivery that has become popular recently are also investigated.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery; Exosome isolation; Exosome loading efficiency; Exosome uptake; Exosomes; Large-scale production

Mesh:

Substances:

Year:  2022        PMID: 35597405     DOI: 10.1016/j.jconrel.2022.05.027

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   11.467


  2 in total

1.  Human Amniotic Fluid Mesenchymal Stem Cell-Derived Exosomes Inhibit Apoptosis in Ovarian Granulosa Cell via miR-369-3p/YAF2/PDCD5/p53 Pathway.

Authors:  Zixiang Geng; Haiyang Chen; Gang Zou; Long Yuan; Peng Liu; Bingrong Li; Kaiyong Zhang; Fangyuan Jing; Xiaoli Nie; Te Liu; Bimeng Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-07-26       Impact factor: 7.310

Review 2.  Cell Membrane-Derived Vesicle: A Novel Vehicle for Cancer Immunotherapy.

Authors:  Caili Xu; Dianwen Ju; Xuyao Zhang
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.